Trial Profile
A Randomized, Open-Label, Two-Way Crossover Study to Determine the Effect of Food on the Pharmacokinetics of a Single JNJ-39823277 (TPI-1062) Dose in Healthy Male and Female Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Aug 2014
Price :
$35
*
At a glance
- Drugs Tianeptine (Primary)
- Indications Major depressive disorder
- Focus Pharmacokinetics
- Sponsors Johnson & Johnson
- 11 Apr 2014 New trial record